ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-10E13326
Home | Market Reports | Health| Health Conditions
Global Idiopathic Thrombocytopenic Purpura ITP Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Insights, Forecast to 2029

Code: QYRE-Auto-10E13326
Report
August 2023
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roch
Amgen Inc
Grifols Biologicals Inc.
GlaxoSmithKline PLC

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size

The global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market is projected to grow from US$ 448.9 million in 2023 to US$ 545.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market

ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike.
Market Analysis and Insights: Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market
Increasing demand for combination therapies therapy is expected to fuel the future growth of the ITP therapeutics market. Clinical evidence suggest that combination therapies entail relatively lower side effects, are cost effective and display higher response rates in patients.
Report Includes
This report presents an overview of global market for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roch, Amgen Inc, Grifols Biologicals Inc. and GlaxoSmithKline Plc, etc.

Scope of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Report

Report Metric Details
Report Name Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market
Accounted market size in 2023 US$ 448.9 million
Forecasted market size in 2029 US$ 545.1 million
CAGR 3.3
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Corticosteroids
  • Intravenous Immunoglobulin (IVIG)
  • Anti-D Immunoglobulin
  • Thrombopoietin Receptor Agonists (TPO-RA)
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roch, Amgen Inc, Grifols Biologicals Inc., GlaxoSmithKline Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market growing?

Ans: The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market witnessing a CAGR of 3.3 during the forecast period 2023-2029.

What is the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market size in 2029?

Ans: The global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market is projected to grow from US$ 448.9 million in 2023 to US$ 545.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Corticosteroids
1.2.3 Intravenous Immunoglobulin (IVIG)
1.2.4 Anti-D Immunoglobulin
1.2.5 Thrombopoietin Receptor Agonists (TPO-RA)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Perspective (2018-2029)
2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Trends by Region
2.2.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Dynamics
2.3.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Trends
2.3.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers
2.3.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Challenges
2.3.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics by Players
3.1.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Concentration Ratio
3.4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2022
3.5 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Head office and Area Served
3.6 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Product and Application
3.7 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Breakdown Data by Type
4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Type (2024-2029)
5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Breakdown Data by Application
5.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2029)
6.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type
6.2.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
6.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application
6.3.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
6.4 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country
6.4.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2029)
7.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type
7.2.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
7.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application
7.3.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
7.4 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country
7.4.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2029)
8.2 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type
8.2.1 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023)
8.2.2 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029)
8.2.3 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
8.3 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application
8.3.1 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023)
8.3.2 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029)
8.3.3 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2029)
9.2 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type
9.2.1 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
9.3 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application
9.3.1 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
9.4 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region
9.4.1 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roch
11.1.1 Roch Company Details
11.1.2 Roch Business Overview
11.1.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.1.4 Roch Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.1.5 Roch Recent Developments
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.2.4 Amgen Inc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.2.5 Amgen Inc Recent Developments
11.3 Grifols Biologicals Inc.
11.3.1 Grifols Biologicals Inc. Company Details
11.3.2 Grifols Biologicals Inc. Business Overview
11.3.3 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.3.4 Grifols Biologicals Inc. Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.3.5 Grifols Biologicals Inc. Recent Developments
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Details
11.4.2 GlaxoSmithKline Plc Business Overview
11.4.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.4.4 GlaxoSmithKline Plc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.4.5 GlaxoSmithKline Plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roch
Amgen Inc
Grifols Biologicals Inc.
GlaxoSmithKline PLC
List of Tables
    Table 1. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Corticosteroids
    Table 3. Key Players of Intravenous Immunoglobulin (IVIG)
    Table 4. Key Players of Anti-D Immunoglobulin
    Table 5. Key Players of Thrombopoietin Receptor Agonists (TPO-RA)
    Table 6. Key Players of Others
    Table 7. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 8. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2018-2023)
    Table 11. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2024-2029)
    Table 13. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Trends
    Table 14. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers
    Table 15. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Challenges
    Table 16. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints
    Table 17. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Share by Players (2018-2023)
    Table 19. Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics as of 2022)
    Table 20. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Ranking 2021 VS 2022 VS 2023
    Table 21. Global 5 Largest Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Headquarters and Area Served
    Table 23. Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Product and Application
    Table 24. Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Type (2018-2023)
    Table 28. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Type (2024-2029)
    Table 30. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Share by Application (2018-2023)
    Table 32. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Share by Application (2024-2029)
    Table 34. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 35. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029) & (US$ Million)
    Table 36. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 37. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029) & (US$ Million)
    Table 38. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 40. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 42. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029) & (US$ Million)
    Table 43. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 44. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029) & (US$ Million)
    Table 45. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 48. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 49. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029) & (US$ Million)
    Table 50. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 51. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029) & (US$ Million)
    Table 52. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 53. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029) & (US$ Million)
    Table 54. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 55. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029) & (US$ Million)
    Table 56. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 57. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 58. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2024-2029) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 64. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 66. Roch Company Details
    Table 67. Roch Business Overview
    Table 68. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
    Table 69. Roch Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
    Table 70. Roch Recent Developments
    Table 71. Amgen Inc Company Details
    Table 72. Amgen Inc Business Overview
    Table 73. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
    Table 74. Amgen Inc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
    Table 75. Amgen Inc Recent Developments
    Table 76. Grifols Biologicals Inc. Company Details
    Table 77. Grifols Biologicals Inc. Business Overview
    Table 78. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
    Table 79. Grifols Biologicals Inc. Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
    Table 80. Grifols Biologicals Inc. Recent Developments
    Table 81. GlaxoSmithKline Plc Company Details
    Table 82. GlaxoSmithKline Plc Business Overview
    Table 83. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
    Table 84. GlaxoSmithKline Plc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
    Table 85. GlaxoSmithKline Plc Recent Developments
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type: 2022 VS 2029
    Figure 3. Corticosteroids Features
    Figure 4. Intravenous Immunoglobulin (IVIG) Features
    Figure 5. Anti-D Immunoglobulin Features
    Figure 6. Thrombopoietin Receptor Agonists (TPO-RA) Features
    Figure 7. Others Features
    Figure 8. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application: 2022 VS 2029
    Figure 10. Hospitals Case Studies
    Figure 11. Clinics Case Studies
    Figure 12. Others Case Studies
    Figure 13. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Report Years Considered
    Figure 14. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region: 2022 VS 2029
    Figure 17. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Players in 2022
    Figure 18. Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2022
    Figure 20. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
    Figure 22. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
    Figure 23. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2029)
    Figure 24. United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY (2018-2029) & (US$ Million)
    Figure 27. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
    Figure 28. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
    Figure 29. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2029)
    Figure 30. Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
    Figure 38. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
    Figure 39. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY (2018-2029) & (US$ Million)
    Figure 40. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
    Figure 41. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
    Figure 42. Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2018-2029)
    Figure 43. Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. China Taiwan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Australia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY (2018-2029) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application (2018-2029)
    Figure 52. Middle East, Africa, and Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2029)
    Figure 53. Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Israel Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. GCC Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 59. Roch Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
    Figure 60. Amgen Inc Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
    Figure 61. Grifols Biologicals Inc. Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
    Figure 62. GlaxoSmithKline Plc Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Pulmonary Exerciser - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20C16992
Thu May 02 00:00:00 UTC 2024

Add to Cart

Medical Nasal Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2P14533
Thu May 02 00:00:00 UTC 2024

Add to Cart

Pediatric Ventricular Assist Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37H14530
Thu May 02 00:00:00 UTC 2024

Add to Cart

Synthetic Fiber Vascular Prosthesis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38F13932
Thu May 02 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions